Consensus Price Target $7.72 $8.00 $8.00 $19.79 Predicted Upside 39.64% Upside 36.59% Upside 36.59% Upside 20.28% Upside Get GoodRx Upgrade and Downgrade Alerts Sign-up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address ...
RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10 RBC Capital analyst Sean Dodge maintains $GoodRx(GDRX.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 41.4% and a total Futu...
GoodRx stock price target cut to $10 from $20 at Deutsche Bank May. 11, 2022 at 9:35 a.m. ETby Tomi Kilgore HealthcareGoodRx Lost a Big Grocer. Analysts Are Concerned. May. 10, 2022 at 1:38 p.m. ETby Barron's MarketsThis Selloff Has Been a Long Time Coming. That Should Ma...
I mean, specifically with BI, what this biosimilar is, is anyone with a prescription regardless of insurance status is going to be able to pay an exclusive cash price of $550 with GoodRx. What's I think nice about this relative to just GoodRx is first, this is our first Biosimilar and...
goodrx is struggling to keep up with the market, let alone outpace it, but it needs to grow at least double the market rate to support the current price target. if the business can barely keep up with the market with all of their strategies in place, then i don't believe they are ...
GoodRx Holdings Price Target Maintained With a $10.00/Share by RBC Capital Dow JonesAug 16 23:20· Ratings RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10 RBC Capital analyst Sean Dodge maintains $GoodRx(GDRX.US)$ with a buy rating, and maintains the ...